RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/36048724 below:

National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2021

. 2022 Sep 2;71(35):1101-1108. doi: 10.15585/mmwr.mm7135a1. National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2021

PMID: 36048724
PMCID: PMC9472778
DOI: 10.15585/mmwr.mm7135a1

Item in Clipboard

National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2021

Cassandra Pingali et al. MMWR Morb Mortal Wkly Rep. 2022.

No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures
FIGURE 1

Estimated vaccination coverage with selected…

FIGURE 1

Estimated vaccination coverage with selected vaccines and doses ^, among adolescents aged 13–17…

FIGURE 1

Estimated vaccination coverage with selected vaccines and doses^, among adolescents aged 13–17 years, by survey year — National Immunization Survey-Teen,^, United States, 2006–2021 Abbreviations: ACIP = Advisory Committee on Immunization Practices; APD = adequate provider data definition; HPV = human papillomavirus; HPV UTD = up to date with HPV vaccination; MenACWY = quadrivalent meningococcal conjugate vaccine; MenB = serogroup B meningococcal vaccine; Tdap = tetanus, diphtheria, and acellular pertussis vaccine. * ≥1 dose Tdap at age ≥10 years; ≥1 dose MenACWY or meningococcal-unknown type vaccine; ≥2 doses MenACWY or meningococcal-unknown type vaccine among adolescents aged 17 years at time of interview. Does not include adolescents who received their first and only dose of MenACWY at age ≥16 years; HPV vaccine includes 9-valent, quadrivalent, or bivalent HPV vaccine. The routine ACIP recommendation for HPV vaccination was made for females in 2006 and for males in 2011. Because HPV vaccination was first recommended for males in 2011, coverage for all adolescents was not measured before that year; HPV UTD includes those with ≥3 doses, and those with 2 doses when the first HPV vaccine dose was initiated at age <15 years and at least 5 months minus 4 days elapsed between the first and second dose. ^† ACIP revised the recommended HPV vaccination schedule in late 2016. The schedule changed from a 3-dose to a 2-dose series with appropriate spacing between receipt of the first and second dose for immunocompetent adolescents initiating the series at age <15 years. Three doses are still recommended for persons initiating the series at age ≥15 years. Because of the change in definition, the graph includes estimates for ≥3 doses of HPV vaccine during 2011–2015 and the HPV UTD estimate during 2016–2021. Because HPV vaccination was first recommended for males in 2011, coverage for all adolescents was not measured before that year. ^§ NIS-Teen implemented a revised APD in 2014 and retrospectively applied the revised APD to 2013 data. Estimates using different APDs might not be directly comparable. ^¶ NIS-Teen moved to a single-sample frame in 2018.

FIGURE 2

Coverage with ≥1 dose of…

FIGURE 2

Coverage with ≥1 dose of human papillomavirus vaccine (A), ≥1 dose of quadrivalent…

FIGURE 2

Coverage with ≥1 dose of human papillomavirus vaccine (A), ≥1 dose of quadrivalent meningococcal conjugate vaccine (B), and ≥1 dose of tetanus, diphtheria, and acellular pertussis vaccine (C), among adolescents in the 2002–2008 annual birth cohorts, by birth year and milestone age — National Immunization Survey-Teen, United States, 2015–2021 Abbreviations: HPV = human papillomavirus; MenACWY = quadrivalent meningococcal conjugate vaccine; Tdap = tetanus, diphtheria, and acellular pertussis vaccine. * Milestone age is the age in years by which the cumulative percent of adolescents vaccinated was assessed and represents vaccination status up to but not including the birthday by which adolescents reached the indicated age.